Zeo ScientifiX (ZEOX) Current Assets (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Current Assets of $3.3 million for Q2 2026, up 277.57% year-over-year from $865000.0 in Q2 2025, and up 62.73% quarter-over-quarter from $2.0 million in Q1 2026.
Zeo ScientifiX (ZEOX) Current Assets (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Current Assets history runs 14 years deep, the most recent figure standing at $3.3 million for Q2 2026.
- In Q2 2026, Current Assets rose 277.57% year-over-year to $3.3 million; the TTM figure through Apr 2026 stood at $3.3 million (up 277.57% YoY), while the FY2025 annual figure was $958000.0, down 17.77% from the prior year.
- Current Assets for Q2 2026 stood at $3.3 million, up from $2.0 million in the prior quarter.
- The five-year high for Current Assets was $4.4 million in Q4 2022, with the low at $355355.0 in Q2 2022.
- The 5-year median for Current Assets is $1.3 million (2024), against an average of $1.6 million.
- Peak annual rise in Current Assets reached 744.22% in 2022, while the deepest fall reached 51.85% in 2022.
- Zeo ScientifiX's Current Assets stood at $4.4 million in 2022, then sank by 49.57% to $2.2 million in 2023, then sank by 47.09% to $1.2 million in 2024, then declined by 17.77% to $958000.0 in 2025, then soared by 240.92% to $3.3 million in 2026.
- Business Quant data shows ZEOX's Current Assets at $3.3 million in Q2 2026, $2.0 million in Q1 2026, and $958000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | 3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3.27 Mn |
| Jan 31, 2026 | 2.01 Mn |
| Oct 31, 2025 | 958,000.00 |
| Jul 31, 2025 | 1.06 Mn |
| Apr 30, 2025 | 865,000.00 |
| Jan 31, 2025 | 1.09 Mn |
| Oct 31, 2024 | 1.17 Mn |
| Jul 31, 2024 | 1.73 Mn |
| Apr 30, 2024 | 1.42 Mn |
| Jan 31, 2024 | 1.89 Mn |
| Oct 31, 2023 | 2.20 Mn |
| Jul 31, 2023 | 1.08 Mn |
| Apr 30, 2023 | 1.77 Mn |
| Jan 31, 2023 | 2.65 Mn |
| Oct 31, 2022 | 4.37 Mn |
| Jul 31, 2022 | 401,581.00 |
| Apr 30, 2022 | 355,355.00 |
| Jan 31, 2022 | 547,946.00 |
| Oct 31, 2021 | 517,194.00 |
| Jul 31, 2021 | 833,953.00 |